IP Library › Granted Patent US 11,576,924
Granted Patent B2
US 11,576,924 · App. 16/611,609 · Granted Feb 14, 2023

Compounds for the prevention and treatment of diseases and the use thereof

Inventors: Eliezer Zomer (Newton, MA); Peter G. Traber (Alpharetta, GA); Raphael Nir (Needham, MA); Sharon Shechter (Andover, MA); Joseph M. Johnson (Arlington, MA); Ryan George (Framingham, MA)
Assignee: GALECTIN SCIENCES, LLC
A61K31/7056A61K45/06A61P1/16A61P9/00A61P13/12C07H17/00C07H17/02C07H99/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,576,924
App. No.
16/611,609
Granted
Feb 14, 2023
Kind
B2
Abstract

Aspects of the invention relate to novel synthetic compounds having binding affinity with galectin proteins.

Claims (5)

1. A compound or a pharmaceutically acceptable salt or solvate thereof having the structure

Structure

2. The compound of claim 1 , wherein the compound has an affinity of about 1 nM to about 50 μM for Galectin-3.

3. A composition comprising a therapeutically effective amount of the compound of claim 1 and a pharmaceutically acceptable adjuvant, excipient, formulation carrier or combinations thereof.

4. A composition comprising a therapeutically effective amount of the compound claim 1 and a therapeutically effective amount of an anti-inflammatory drug, vitamin, pharmaceutical drug, nutraceutical drug, supplement, or combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2021
From: ZOMER, ELIEZER; TRABER, PETER G.; NIR, RAPHAEL; SHECHTER, SHARON; JOHNSON, JOSEPH M.; GEORGE, RYAN
To: GALECTIN SCIENCES, LLC
Reel/Frame 055620/0085 →
Continuity (2)
Provisional Application 62505544 · May 12, 2017
Related Publication 20200155586A1 · May 21, 2020